107 related articles for article (PubMed ID: 26348270)
1. Angiotensin peptides attenuate platelet-activating factor-induced inflammatory activity in rats.
Sato A; Yokoyama I; Ebina K
Peptides; 2015 Nov; 73():60-6. PubMed ID: 26348270
[TBL] [Abstract][Full Text] [Related]
2. An endothelin-3-related synthetic biotinylated pentapeptide as a novel inhibitor of platelet-activating factor.
Sato A; Suzuki T; Oikawa K; Ohta R; Ebina K
Eur J Pharmacol; 2013 Aug; 714(1-3):142-7. PubMed ID: 23792041
[TBL] [Abstract][Full Text] [Related]
3. Synthetic biotinylated peptide compounds derived from Asp-hemolysin: novel potent inhibitors of platelet-activating factor.
Sato A; Kumagai T; Aoki J; Ebina K
Eur J Pharmacol; 2012 Jun; 685(1-3):205-12. PubMed ID: 22542654
[TBL] [Abstract][Full Text] [Related]
4. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE
Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804
[TBL] [Abstract][Full Text] [Related]
5. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo.
Sato A; Oe K; Yamanaka H; Yokoyama I; Ebina K
Eur J Pharmacol; 2014 Dec; 745():46-51. PubMed ID: 25455842
[TBL] [Abstract][Full Text] [Related]
7. Biotinylated heptapeptides substituted with a D-amino acid as platelet-activating factor inhibitors.
Sato A; Yokoyama I; Ebina K
Eur J Pharmacol; 2015 Oct; 764():202-207. PubMed ID: 26142829
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw.
Fernandes ES; Passos GF; Campos MM; Araújo JG; Pesquero JL; Avelllar MC; Teixeira MM; Calixto JB
Br J Pharmacol; 2003 Jul; 139(5):973-81. PubMed ID: 12839871
[TBL] [Abstract][Full Text] [Related]
9. AT1 receptor antagonism enhances angiotensin-II-facilitated carrageenan-induced paw edema.
Raghavendra V; Kulkarni SK
Methods Find Exp Clin Pharmacol; 2000 Oct; 22(8):633-6. PubMed ID: 11256235
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptors.
Ardaillou R
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S30-9. PubMed ID: 9892138
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-3 at low concentrations attenuates inflammatory responses via the endothelin B2 receptor.
Sato A; Ebina K
Inflamm Res; 2013 Apr; 62(4):417-24. PubMed ID: 23370722
[TBL] [Abstract][Full Text] [Related]
12. A biotinylated peptide, BP21, as a novel potent anti-anaphylactic agent targeting platelet-activating factor.
Sato A; Ebina K
J Pept Sci; 2017 Sep; 23(9):727-735. PubMed ID: 28627122
[TBL] [Abstract][Full Text] [Related]
13. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
Kassuya CA; Silvestre A; Menezes-de-Lima O; Marotta DM; Rehder VL; Calixto JB
Eur J Pharmacol; 2006 Sep; 546(1-3):182-8. PubMed ID: 16925995
[TBL] [Abstract][Full Text] [Related]
14. Influence of acyl and plasmalogenic analogs of platelet activating factor on chemotaxis of human leukocytes in vitro and their inflammatory and antiinflammatory activity in vivo.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2002 Nov; 67(11):1248-52. PubMed ID: 12495421
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin peptides regulate angiogenic activity in rat anterior pituitary tumour cell cultures.
Ptasińska-Wnuk D; Lawnicka H; Fryczak J; Kunert-Radek J; Pawlikowski M
Endokrynol Pol; 2007; 58(6):478-86. PubMed ID: 18205103
[TBL] [Abstract][Full Text] [Related]
16. The effect of angiotensin 1-7 on tyrosine kinases activity in rat anterior pituitary.
Rebas E; Zabczyńska J; Lachowicz A
Biochem Biophys Res Commun; 2006 Sep; 347(3):581-5. PubMed ID: 16842749
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 2 receptor provides an endogenous brake during inflammation-induced microvascular fluid leak.
Ereso AQ; Ramirez RM; Sadjadi J; Cripps MW; Cureton EL; Curran B; Victorino GP
J Am Coll Surg; 2007 Oct; 205(4):527-33. PubMed ID: 17903725
[TBL] [Abstract][Full Text] [Related]
18. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
[TBL] [Abstract][Full Text] [Related]
19. Desensitization to PAF-induced rat paw oedema by repeated intraplantar injections.
Cordeiro RS; Martins MA; Silva PM; Faria Neto HC; Castanheira JR; Vargaftig BB
Life Sci; 1986 Nov; 39(20):1871-8. PubMed ID: 3773645
[TBL] [Abstract][Full Text] [Related]
20. Contractile effects of angiotensin peptides in rat aorta are differentially dependent on tyrosine kinase activity.
Petrescu G; Costuleanu M; Slatineanu SM; Costuleanu N; Foia L; Costuleanu A
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):180-7. PubMed ID: 11881120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
